Why the Bull Case for Intuitive Surgical Stock Is Long Term Medical Robotics Dominance

Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.
Surgical systems, rehabilitation, elderly care, prosthetics

Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.

Microbot Medical trades under $1 because clinical approval remains unproven and revenue is minimal while cash burn continues relentlessly.

MDAI is not the next Google of medical robotics, despite what the ticker symbol and marketing language might suggest.

Microbot Medical Inc. (NASDAQ: MBOT) is not the next Nvidia in the sense of semiconductor manufacturing, but it represents something equally...

Medical robotics could produce the next Nvidia because it's following the exact playbook that made Nvidia dominant in AI: become the foundational...

Intuitive Surgical (ISRG) functions as the dominant platform provider in surgical robotics much the same way NVIDIA dominates AI compute...

MBOT represents a speculative bet on the future of medical automation—the unproven belief that robotic systems will eventually handle a significant...

Microbot Medical's LIBERTY Endovascular Robotic System represents a fundamental shift in how interventional procedures are performed, much like Nvidia's...

Intuitive Surgical has earned comparisons to Nvidia not because both companies make the same products, but because both have established near-monopolistic...

Microbot Medical (NASDAQ: MBOT) has emerged as a compelling player in the medical robotics space, earning comparisons to Nvidia's dominance in its...